Navitas: Fundamentals Are Bearish But You Can't Fight Animal Spirits (Archive) Balancing bearish fundamentals with exuberant technicals, I rate Navitas a cautious Hold.
Ares Capital: Risks You Should Not Ignore Before The Q3 Release (Archive) Rate cuts, portfolio stresses, and rich valuation threaten Ares Capital’s future returns.
Tesla Q3 Preview: What To Focus On And What To Overlook (Archive) Robotaxis and humanoid robots increasingly justify Tesla’s lofty valuation and bullish outlook.
Did Pfizer Overpay For Yet Another Acquisition? (Archive) Pfizer’s Metsera obesity deal looks reasonably priced, but fundamentals still justify only a hold.
Credo: I Sold This Way Too Soon (Archive) Credo sits at the heart of surging AI data center networking demand.
TSMC: Unprecedented Growth Outlook For A Company Of This Scale (Archive) TSMC’s AI-driven growth, expanding margins, and discounted valuation make it compelling today.
Advanced Micro Devices: What You Need To Know About The Deal With OpenAI (Archive) AMD’s OpenAI mega deal offers huge upside but raises dilution, margin, and valuation risks.